high potency active pharmaceutical ingredients (HPAPIs)

Demand for high potent active pharmaceutical ingredients is driving the need for high potency handling capabilities. Here, Mike Avraam, global product manager for ChargePoint PharmaSafe, ChargePoint Technology, discusses this growing sector in detail more

27 Sep 2017 13:58 Opinion

Sylvain Querol (MEng), tendering manager, Europe, at Powder Systems Limited on how to achieve high containment for HPAPI small-scale production. more

27 Dec 2016 09:00 News

As 2015 is beginning to wrap up European Pharmaceutical Manufacturer has looked at our most popular stories more

8 Dec 2015 14:57 News

Capsugel is set to more than double the size of its facility in Edinburgh, Scotland, enabling the company to meet rising customer demand for its liquid- and semi-solid-fill hard capsule development and manufacturing services. more

23 Jul 2015 15:55 News

Reddy made

Dr. Reddy's Custom Pharmaceutical Services (CPS) explains the integration of highly potent drug substance and drug product manufacturing. more

3 Oct 2014 11:04 Guest Blogs

Novasep’s €4 million (£3.3/$5.5 million) investment to expand its highly potent active pharmaceutical ingredients (HPAPIs) manufacturing capabilities at its Le Mans facility in France has reached fruition. The plant extension has been fully... more

15 May 2014 13:58 Technology

Dec Group multi-purpose isolators are designed for use in pharmaceutical manufacturing areas for the contamination-free handling of HPAPIs. The containment systems are developed with Dec’s ergonomic package to offer ease of use and an ultra-safe ... more

23 Jan 2014 15:14 Technology

Novasep has announced that the FDA successfully audited two of its European custom manufacturing sites in Le Mans, France and Leverkusen, Germany. FDA investigators audited the two facilities in June and July 2013. more

22 Oct 2013 11:14 Technology

To meet rising demand for high potency active pharmaceutical ingredients (HPAPIs) spurred by the growing targeted therapy approach in the treatment of diseases, in particular oncology, Switzerland-based CARBOGEN AMCIS has completed a capital... more

16 Oct 2013 10:50 Technology

Sigma-Aldrich Corporation’s custom manufacturing services business unit, SAFC Commercial (, is expanding two of its manufacturing facilities in the US to support drug manufacturers in efficiently bringing new targeted... more

15 Oct 2013 14:33 Technology